Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) spanning five years due to the United States' demand for confidential information.
This move became public following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman later explained that the US was requesting health data for research and commercial gain while was unwilling to guarantee the benefits from any future treatments.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.
Broader Implications
This rejection comes after a similar case in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were raised about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government deals to boost transparency and accountability.
According to reports, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our nation would provide the basic resources for medical research with no certainty that the resulting innovations would be available to our population if a future disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage potential pandemics.
"This framework is intended to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further dialogue with our US partners on how subsequent co-operation might be arranged in a way that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that talks need to persist given that much of the nation's HIV programmes relied on international support.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it said.
The halted deal emphasises the continuing debate between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.